IHM
NERV icon

Iguana Healthcare Management’s Minerva Neurosciences NERV Stock Holding History

Iguana Healthcare Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,500
Closed -$810K – 69
2017
Q1 		$810K Sell
12,500
-6,250
-33% -$485K 0.4% 61
2016
Q4 		$1.76M Sell
18,750
-37,500
-67% -$3.83M 1.05% 33
2016
Q3 		$6.35M Buy
56,250
+40,625
+260% +$3.94M 1.13% 31
2016
Q2 		$1.28M Buy
+15,625
New +$993K 0.52% 61

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Iguana Healthcare Management's NERV Position: Q2 2017 in Review

Iguana Healthcare Management sold out of Minerva Neurosciences (NERV) in Q2 2017, closing a stake of 12,500 shares — an estimated $810K sold.

Iguana Healthcare Management first reported a position in NERV in Q2 2016 and held it in 4 quarters. The position peaked at $6.35M in Q3 2016. 82 funds tracked by Wall St. Rank hold NERV as of Q2 2017.

  • Iguana Healthcare Management reported no remaining Minerva Neurosciences position as of Q2 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 12,500 Minerva Neurosciences shares in Q2 2017, an estimated $810K.
  • Iguana Healthcare Management first reported a position in Minerva Neurosciences in Q2 2016 and held it in 4 quarters.
  • Iguana Healthcare Management's Minerva Neurosciences position peaked at $6.35M in Q3 2016.
  • 82 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2017.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.